NK cell vesicles-based nanoplatform loaded with sorafenib synergizing ferroptosis and antitumor immunity against hepatocellular carcinoma
Chulan Gong, Shenjie Zhang, Yuting Fan, Dan Liang, Zailing Yang, Jing Zhang, Xiong Liu, Ting Guo, Xinlan Li, Tao Shen, Changya Li, Xing Zhao, Shi Zuo · 2026
Read NK cell vesicles-based nanoplatform loaded with sorafenib synergizing ferroptosis and antitumor immunity against hepatocellular carcinoma by Chulan Gong, Shenjie Zhang, Yuting Fan, Dan Liang, Zailing Yang, Jing Zhang, Xiong Liu, Ting Guo, Xinlan Li, Tao Shen, Changya Li, Xing Zhao, Shi Zuo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479734.txt.
Description
Chulan Gong and twelve colleagues built in 2026 a natural killer cell vesicle platform carrying sorafenib against liver cancer. Ferroptosis, an iron-driven form of cell death, offers a fresh angle on tumours that resist standard treatment.
They loaded sorafenib into vesicles squeezed from natural killer cells, a design that dodges drug-efflux pumps and triggers ferroptosis in cancer cells. Dying cells released danger signals that sparked immunogenic cell death, and in mice the treatment curbed tumour growth by about 45 percent while drawing killer T cells into tumours. Pairing ferroptosis with immune activation thus opens a new route for hepatocellular carcinoma therapy.
Catalog record
| CREATOR | Chulan Gong, Shenjie Zhang, Yuting Fan, Dan Liang, Zailing Yang, Jing Zhang, Xiong Liu, Ting Guo, Xinlan Li, Tao Shen, Changya Li, Xing Zhao, Shi Zuo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |